Diagnostic Imaging Companies

The global diagnostic imaging market is projected to reach USD 32.90 billion by 2030 from USD 26.51 billion in 2025, at a CAGR of 4.4% from 2025 to 2030. The growing prevalence of targeted diseases and technological advancements are driving market growth. There is an increasing demand for noninvasive diagnostic methods, such as breast cancer screening (mammography) and lung cancer screening (low-dose CT), which is contributing to a rise in imaging volume for various conditions.

The diagnostic imaging market is moderately competitive, featuring both established companies and emerging competitors vying for the same market share.

As of 2024, the key players operating in the global diagnostic imaging market are Siemens Healthineers (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Corporation (Japan), and Canon Inc. (Japan). In 2024, Siemens Healthineers (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), and FUJIFILM Corporation (Japan) held a larger share of the diagnostic imaging market.

To know about the assumptions considered for the study download the pdf brochure

Siemens Healthineers (Germany) is a leading player in the diagnostic imaging market due to its strong portfolio of imaging products that includes MRI, ultrasound, X-ray systems, and nuclear imaging devices. It has significant research and development facilities located in Germany, the US, China, and India. The company offers a wide range of products and services in point-of-care diagnostics, laboratory assessments, diagnostic and therapeutic evaluations, and molecular medicine. With a direct presence in over 70 countries across Europe, the Americas, Asia, Oceania, Africa, and the Middle East, the company boasts an extensive geographic reach. Its primary production facilities are situated in the US, Germany, and China. The company is committed to investing in research and development to introduce cutting-edge and technologically advanced products. It distributes its products in over 180 nations through various distributors and sales networks.

GE HealthCare (US) offers a diverse range of products in medical imaging and information technology, medical diagnostics, disease research, biopharmaceutical production, drug development, and related technologies. Its portfolio includes a variety of diagnostic solutions, such as molecular imaging, ultrasound, and magnetic resonance imaging techniques. The company has an extensive global presence, operating in over 160 countries across North America, South America, Europe, the Middle East, Asia Pacific, and Africa.

Koninklijke Philips N.V. (Netherlands) is a leading company in the fields of diagnostic imaging, patient monitoring, image-enhanced therapy, and health informatics. Within its Diagnosis & Treatment division, Philips offers solutions for diagnostic imaging, image-guided therapy, and ultrasound. The company focuses primarily on inorganic growth strategies, such as collaborations and alliances, to strengthen its position in the imaging sector. Operating globally, Philips has a sales and service network that spans over 100 countries. Some of its subsidiaries include Philips Medical Systems in Belgium and Philips Electronics India Limited in India, among others.

Market Ranking (2024):

The global diagnostic imaging market is moderately competitive, featuring the top five players: Siemens Healthineers (Germany), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), FUJIFILM Corporation (Japan), and Canon Inc. (Japan), among others. Key participants in the diagnostic imaging market were identified through secondary research, and their market shares (in terms of value) were assessed based on various factors, including the products offered, segmental revenue analysis, geographic presence, recent market developments, and overall market positioning.

To validate revenues and market shares, primary research interviews were conducted with industry leaders such as chief executive officers, directors, experts, and other executives.

Most primary stakeholders in this market are located in the US. The competitive landscape also shows a significant presence of numerous smaller companies that serve both regional and global markets. Companies are increasingly focusing on research and development initiatives to diversify their product offerings and strengthen their competitive positions. Additionally, there is a strong incentive for market participants to expand their reach into the Asia Pacific and Latin American regions, driven by the attractive growth opportunities these markets provide.

Related Reports:

Diagnostic Imaging Market by Modality (MRI (Very High (7T+), High (3T+), Low (<3T)), Ultrasound (3D/4D, Doppler, Contrast), CT, X-Ray (Digital, Portable), Mammography, SPECT, PET)), Application (OB/Gyn, CVD, Onco, Neuro) & End User - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com